Elicio Therapeutics Inc — Balance Sheet (NASDAQ:ELTX) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Total assets 96.51 M52.79 M27.15 M28.18 M Total liabilities 15.01 M9.02 M15.77 M39.49 M Total equity 81.51 M43.77 M11.37 M11.31 M Total liabilities & shareholders' equities 96.51 M52.79 M27.15 M28.18 M Total debt 0——— Net debt -88.8 M———

Notícias

Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?

Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why

Elicio reports antigen spreading in 87% of evaluated cancer patients

Elicio Therapeutics appoints Marc Wolfgang as chief technology officer

Elicio reports strong immune responses in phase 2 KRAS cancer vaccine trial

Elicio’s cancer therapy shows immune response across diverse HLA types

Vacina contra câncer ELI-002 da Elicio mostra forte resposta imunológica em 99% dos pacientes

Elicio’s cancer vaccine ELI-002 shows strong immune response in 99% of patients

Elicio (ELTX) Q2 Loss Beats Estimates

H.C. Wainwright raises Elicio Therapeutics stock price target to $13 on trial outlook

Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer

Elicio secures $10 million to extend cash runway